Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is providing ...
There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...
Abstract: Among various renewable energy resources, solar power holds tremendous potential to address the challenge of depleting non-renewable energy sources. In contemporary times, an increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback